Right on schedule, the first cycle of the new Medicare Drug Price Negotiation Program (MDPNP) took effect on January 1, 2026, imposing a “maximum fair price” on 10 specific drugs dispensed to Medicare Part D beneficiaries. As predicted, the program has generated concern and confusion among independent pharmacies, with reduced payments, new compliance requirements, and growing cash-flow challenges reshaping how pharmacies operate in the new pricing era. Read More >



